Literature DB >> 7011250

Attention deficit disorder ('minimal brain dysfunction') in adults. A replication study of diagnosis and drug treatment.

P H Wender, F W Reimherr, D R Wood.   

Abstract

This study replicated an earlier one dealing with the diagnosis and treatment of attention deficit disorder (ADD, or minimal brain dysfunction) in adults. Subjects who met provisional operational criteria for adult ADD were entered in a random-assignment, parallel, double-blind trial of placebo and pemoline, a noneuphorigenic psychostimulant drug effective in children with ADD. There was improvement in both the pemoline group and the placebo group, but the difference in improvement was not statistically significant. When the analyses were confined to that subgroup of patients whose parents had described them in the 95th percentile of childhood "hyperactivity" or when the hyperactivity score was partialled out statistically, pemoline was demonstrably more effective than placebo. Revised operational criteria for adult ADD are proposed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7011250     DOI: 10.1001/archpsyc.1981.01780290083009

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  18 in total

Review 1.  An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults.

Authors:  Timothy E Wilens; Nicholas R Morrison; Jefferson Prince
Journal:  Expert Rev Neurother       Date:  2011-10       Impact factor: 4.618

2.  Psychiatry: attention-deficit disorder in children-diagnosis and treatment.

Authors:  D P Cantwell
Journal:  West J Med       Date:  1985-05

3.  Lack of gender effects on subtype outcomes in adults with attention-deficit/hyperactivity disorder: support for the validity of subtypes.

Authors:  Eugenio H Grevet; Claiton H D Bau; Carlos A I Salgado; Aline G Fischer; Katiane Kalil; Marcelo M Victor; Christiane R Garcia; Nyvia O Sousa; Luis A Rohde; Paulo Belmonte-de-Abreu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-05-12       Impact factor: 5.270

Review 4.  Emotion dysregulation in attention deficit hyperactivity disorder.

Authors:  Philip Shaw; Argyris Stringaris; Joel Nigg; Ellen Leibenluft
Journal:  Am J Psychiatry       Date:  2014-03       Impact factor: 18.112

5.  Driving-related risks and impact of methylphenidate treatment on driving in adults with attention-deficit/hyperactivity disorder (ADHD).

Authors:  E Sobanski; D Sabljic; B Alm; G Skopp; N Kettler; R Mattern; P Strohbeck-Kühner
Journal:  J Neural Transm (Vienna)       Date:  2008-01-16       Impact factor: 3.575

Review 6.  Dual diagnosis.

Authors:  M F Sheehan
Journal:  Psychiatr Q       Date:  1993

7.  [Attention deficit hyperactivity disorder in adults. An overview].

Authors:  E Sobanski; B Alm
Journal:  Nervenarzt       Date:  2004-07       Impact factor: 1.214

8.  Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents.

Authors:  R Cumin; E F Bandle; E Gamzu; W E Haefely
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 9.  Drug therapy for adults with attention-deficit hyperactivity disorder.

Authors:  Timothy E Wilens
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  The association between attention-deficit/hyperactivity disorder and early-onset alcohol dependence: A retrospective study.

Authors:  Sujaya Kumara R Sringeri; Ravi Philip Rajkumar; Kesavan Muralidharan; Channapatna R Chandrashekar; Vivek Benegal
Journal:  Indian J Psychiatry       Date:  2008-10       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.